{
  "symbol": "exel",
  "name": "Exelixis, Inc.",
  "ipoYear": 2000,
  "sector": "Health Care",
  "industry": "Biotechnology: Commercial Physical & Biological Resarch",
  "exchange": "nasdaq",
  "category": "SERVICES-COMMERCIAL PHYSICAL &amp;amp; BIOLOGICAL RESEARCH",
  "address": {
    "street1": "210 E. GRAND AVE",
    "city": "SOUTH SAN FRANCISCO",
    "state": "CA",
    "zip": "94080"
  },
  "profit": {
    "2009": -135220000,
    "2010": -92330000,
    "2011": 75697000,
    "2012": -147645000,
    "2013": -244760000
  },
  "cash": {
    "2009": 86796000,
    "2010": 97440000,
    "2011": 74257000,
    "2012": 170069000,
    "2013": 103978000
  },
  "earningsPerShare": {
    "2009": -1.26,
    "2010": -0.85,
    "2011": 0.6,
    "2012": -0.92,
    "2013": -1.33
  },
  "htmlUrl": "http://www.sec.gov/Archives/edgar/data/939767/000093976714000009/0000939767-14-000009-index.htm",
  "xmlUrl": "http://www.sec.gov/Archives/edgar/data/939767/000093976714000009/exel-20131231.xml"
}